At least the damage at Theranos was confined to professional investors, Reuters writes in this opinion piece. Elizabeth Holmes’ blood-testing outfit touted novel technology and big future sales before its collapse. Holmes, whose trial starts today, blurred the lines between marketing and fraud, and Theranos’ multibillion-dollar private-market valuation dwindled to nothing. Fast forward and Trevor Milton, founder of electric-truck firm Nikola is facing similar charges. Nikola, though, has publicly traded shares. Read more.
Billionaire investor Sam Zell told CNBC today that some deals involving SPACs remind him of the speculation in internet companies during the 1990s dot-com bubble.
The fireside chat will begin today at 3:30 p.m. Eastern.